CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 532095-532291 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/ee0a7632371a08727d41e55aad7d621daeceef7d","sourcedb":"CORD-19","sourceid":"ee0a7632371a08727d41e55aad7d621daeceef7d","text":"In this study we investigate TP53 and LKB1/STK11 mutation co-occurrence with major subtypes of KRAS as potential biomarkers for efficacy of MEK inhibitors in NSCLC patients within our institution.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T54298","span":{"begin":0,"end":196},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T54298","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T310","span":{"begin":0,"end":196},"obj":"Sentence"}],"attributes":[{"subj":"T310","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T1041","span":{"begin":158,"end":163},"obj":"Phenotype"}],"attributes":[{"id":"A1041","pred":"hp_id","subj":"T1041","obj":"http://purl.obolibrary.org/obo/HP_0030358"},{"subj":"T1041","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2559","span":{"begin":158,"end":163},"obj":"Disease"},{"id":"T2512","span":{"begin":158,"end":163},"obj":"Disease"}],"attributes":[{"id":"A2559","pred":"mondo_id","subj":"T2559","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A84752","pred":"mondo_id","subj":"T2512","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"subj":"T2559","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T2512","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#eceb93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#d193ec"},{"id":"CORD-19-PD-HP","color":"#93ecb7"},{"id":"CORD-19-PD-MONDO","color":"#ec9d93"}]}]}}